EUVIMEDEUVIMED entdecken
Crossref

Structural optimization of phthalazine derivatives for anti-HBV activities to improve oral bioavailability

Yurong Yang, Fuling Xiao, Jianping Zuo, Li Yang, Youhong Hu, Wuhong Chen

Bioorganic & Medicinal Chemistry · 2025

DOI: 10.1016/j.bmc.2025.118259 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry, 2025. Verfasst von Yurong Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 ZuChongZhi Road, Shanghai 201203, China…. Hauptthemen laut MEDLINE: Phthalazines, Antiviral Agents, Hepatitis B virus. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Science and Technology Innovation Plan Of Shanghai Science and Technology Commission, National Natural Science Foundation of China, National Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The hepatitis B virus (HBV) capsid protein forms a protective nucleocapsid essential for viral replication, establishing capsid assembly modulation as a promising therapeutic strategy. Based on previous mechanistic studies, we identified phthalazine derivatives as potent HBV capsid assembly modulators (CAMs), with Yhhu6517 exhibiting submicromolar antiviral activity in vitro. However, its clinical translation was hindered by poor oral pharmacokinetics (PK), due to rapid first-pass metabolism of oxidation-prone primary alcohol groups. Through metabolic stability-guided structure-activity relationship (SAR) studies involving systematic replacement of primary alcohols with non-primary alcohol-derived hydrophilic groups, we optimized the fragments to yield compound 2p. This optimized candidate 2p maintained a potent anti-HBV activity (IC50 = 0.016 μM in HepG2.2.15 cells) while demonstrating improved an oral bioavailability (F = 80.6 % in mice) and enhanced plasma exposure (AUC0-24h = 10.3 μg·h/mL). These findings confirm phthalazine-based anti-HBV agents, with compound 2p emerging as a candidate for the further development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhthalazinesAntiviral AgentsHepatitis B virusHumansStructure-Activity RelationshipAnimalsBiological AvailabilityAdministration, OralMiceHep G2 CellsMolecular StructureMicrobial Sensitivity TestsDose-Response Relationship, DrugMale

Stichwörter der Autor:innen

Capsid assembly modulatorsHBVOxidative metabolismStructural optimization

Substanzen

PhthalazinesAntiviral Agentsphthalazine

Autor:innen und Institutionen

  • State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 ZuChongZhi Road, Shanghai 201203, China; School of Chinese Materia Medica, College of Pharmacy, Nanjing Unive…
  • State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 ZuChongZhi Road, Shanghai 201203, China; Immunological Disease Research Center, Shanghai Institute of Materia…
  • State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 ZuChongZhi Road, Shanghai 201203, China; University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beij…
  • State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 ZuChongZhi Road, Shanghai 201203, China. Electronic address: whchen@simm.ac.cn.

Förderung

  • Science and Technology Innovation Plan Of Shanghai Science and Technology Commission
  • National Natural Science Foundation of China
  • National Science and Technology Major Project

Zitieren

APA

Yang, Y., Xiao, F., Zuo, J., Yang, L., Hu, Y., & Chen, W. (2025). Structural optimization of phthalazine derivatives for anti-HBV activities to improve oral bioavailability. Bioorganic & Medicinal Chemistry. https://doi.org/10.1016/j.bmc.2025.118259

Vancouver

Yang Y, Xiao F, Zuo J, Yang L, Hu Y, Chen W. Structural optimization of phthalazine derivatives for anti-HBV activities to improve oral bioavailability. Bioorganic & Medicinal Chemistry. 2025. doi:10.1016/j.bmc.2025.118259

BibTeX
@article{Yang2025,
  author = {Yang, Yurong and Xiao, Fuling and Zuo, Jianping and Yang, Li and Hu, Youhong and Chen, Wuhong},
  title = {Structural optimization of phthalazine derivatives for anti-HBV activities to improve oral bioavailability},
  journal = {Bioorganic & Medicinal Chemistry},
  year = {2025},
  doi = {10.1016/j.bmc.2025.118259}
}
Kostenlos starten →